aluates Reports

$ 0.0

Automative

Inflammatory Bowel Disease - Global Market Insights and Sales Trends 2024

Published Date: December 2023

Report Code: QYRE-Auto-39W5849

Global Inflammatory Bowel Disease Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Inflammatory Bowel Disease - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-39W5849

Report

December 2023

Pages:104

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bristol Myers Squibb Company

Baxter International

Johnson & Johnson

Sanofi Aventis

Abbott Laboratories

Pluristem Therapeutics

Pfizer Inc

Astrazeneca plc

Cephalon

Amgen Inc

Inflammatory Bowel Disease - Market Size

The global Inflammatory Bowel Disease market size is expected to reach US$ 16820 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029.

Inflammatory Bowel Disease - Market

Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stomach and the anus, whereas ulcerative colitis primarily affects the colon and the rectum.

The market is mainly driven by the significant applications of Inflammatory Bowel Disease in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Inflammatory Bowel Disease market. Aminosalicylates, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antibiotics segment is estimated at % CAGR for the next seven-year period.

Medical treatment of IBD is individualised to each patient. The choice of which drugs to use and by which route to administer them (oral, rectal, injection, infusion) depends on factors including the type, distribution, and severity of the patient's disease, as well as other historical and biochemical prognostic factors, and patient preferences. For example, mesalazine is more useful in ulcerative colitis than in Crohn's disease. Generally, depending on the level of severity, IBD may require immunosuppression to control the symptoms, with drugs such as prednisone, TNF inhibitors, azathioprine (Imuran), methotrexate, or 6-mercaptopurine.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Inflammatory Bowel Disease, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Inflammatory Bowel Disease market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Inflammatory Bowel Disease market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Inflammatory Bowel Disease sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Inflammatory Bowel Disease covered in this report include Bristol-Myers Squibb Company, Baxter International, Johnson & Johnson, Sanofi-Aventis, Abbott Laboratories, Pluristem Therapeutics, Pfizer, AstraZeneca and Cephalon, etc.

The global Inflammatory Bowel Disease market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Bristol-Myers Squibb Company

Baxter International

Johnson & Johnson

Sanofi-Aventis

Abbott Laboratories

Pluristem Therapeutics

Pfizer

AstraZeneca

Cephalon

Amgen

Scope of Inflammatory Bowel Disease - Market Report

Report Metric	Details
Report Name	Inflammatory Bowel Disease - Market
Forecasted market size in 2029	US$ 16820 million
CAGR	3.5%
Forecasted years	2023 - 2029
Global Inflammatory Bowel Disease market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Inflammatory Bowel Disease market, Segment by Type:	Aminosalicylates Antibiotics Corticosteroids Biologic therapies (biological drugs) Others
Global Inflammatory Bowel Disease market, by Application	Hospital Clinic Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Inflammatory Bowel Disease companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Inflammatory Bowel Disease - Market size in 2029?

Ans: The Inflammatory Bowel Disease - Market size in 2029 will be US$ 16820 million.

What are the Application segmentation covered in the Inflammatory Bowel Disease - Market report?

Ans: The Applications covered in the Inflammatory Bowel Disease - Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Inflammatory Bowel Disease - Market report?

Ans: The Types covered in the Inflammatory Bowel Disease - Market report are Aminosalicylates, Antibiotics, Corticosteroids, Biologic therapies (biological drugs), Others

1 Market Overview of Inflammatory Bowel Disease

1.1 Inflammatory Bowel Disease Market Overview

1.1.1 Inflammatory Bowel Disease Product Scope

1.1.2 Inflammatory Bowel Disease Market Status and Outlook

1.2 Global Inflammatory Bowel Disease Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Inflammatory Bowel Disease Market Size by Region (2018-2029)

1.4 Global Inflammatory Bowel Disease Historic Market Size by Region (2018-2023)

1.5 Global Inflammatory Bowel Disease Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Inflammatory Bowel Disease Market Size (2018-2029)

1.6.1 North America Inflammatory Bowel Disease Market Size (2018-2029)

1.6.2 Europe Inflammatory Bowel Disease Market Size (2018-2029)

1.6.3 Asia-Pacific Inflammatory Bowel Disease Market Size (2018-2029)

1.6.4 Latin America Inflammatory Bowel Disease Market Size (2018-2029)

1.6.5 Middle East & Africa Inflammatory Bowel Disease Market Size (2018-2029)

2 Inflammatory Bowel Disease Market by Type

2.1 Introduction

2.1.1 Aminosalicylates

2.1.2 Antibiotics

2.1.3 Corticosteroids

2.1.4 Biologic therapies (biological drugs)

2.1.5 Others

2.2 Global Inflammatory Bowel Disease Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Inflammatory Bowel Disease Historic Market Size by Type (2018-2023)

2.2.2 Global Inflammatory Bowel Disease Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Inflammatory Bowel Disease Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Inflammatory Bowel Disease Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Inflammatory Bowel Disease Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Inflammatory Bowel Disease Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Inflammatory Bowel Disease Revenue Breakdown by Type (2018-2029)

3 Inflammatory Bowel Disease Market Overview by Application

3.1 Introduction

3.1.1 Hospital

3.1.2 Clinic

3.1.3 Others

3.2 Global Inflammatory Bowel Disease Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Inflammatory Bowel Disease Historic Market Size by Application (2018-2023)

3.2.2 Global Inflammatory Bowel Disease Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Inflammatory Bowel Disease Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Inflammatory Bowel Disease Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Inflammatory Bowel Disease Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Inflammatory Bowel Disease Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Inflammatory Bowel Disease Revenue Breakdown by Application (2018-2029)

4 Inflammatory Bowel Disease Competition Analysis by Players

4.1 Global Inflammatory Bowel Disease Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease as of 2022)

4.3 Date of Key Players Enter into Inflammatory Bowel Disease Market

4.4 Global Top Players Inflammatory Bowel Disease Headquarters and Area Served

4.5 Key Players Inflammatory Bowel Disease Product Solution and Service

4.6 Competitive Status

4.6.1 Inflammatory Bowel Disease Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Bristol-Myers Squibb Company

5.1.1 Bristol-Myers Squibb Company Profile

5.1.2 Bristol-Myers Squibb Company Main Business

5.1.3 Bristol-Myers Squibb Company Inflammatory Bowel Disease Products, Services and Solutions

5.1.4 Bristol-Myers Squibb Company Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)

5.1.5 Bristol-Myers Squibb Company Recent Developments

5.2 Baxter International

5.2.1 Baxter International Profile

5.2.2 Baxter International Main Business

5.2.3 Baxter International Inflammatory Bowel Disease Products, Services and Solutions

5.2.4 Baxter International Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)

5.2.5 Baxter International Recent Developments

5.3 Johnson & Johnson

5.3.1 Johnson & Johnson Profile

5.3.2 Johnson & Johnson Main Business

5.3.3 Johnson & Johnson Inflammatory Bowel Disease Products, Services and Solutions

5.3.4 Johnson & Johnson Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)

5.3.5 Sanofi-Aventis Recent Developments

5.4 Sanofi-Aventis

5.4.1 Sanofi-Aventis Profile

5.4.2 Sanofi-Aventis Main Business

5.4.3 Sanofi-Aventis Inflammatory Bowel Disease Products, Services and Solutions

5.4.4 Sanofi-Aventis Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)

5.4.5 Sanofi-Aventis Recent Developments

5.5 Abbott Laboratories

5.5.1 Abbott Laboratories Profile

5.5.2 Abbott Laboratories Main Business

5.5.3 Abbott Laboratories Inflammatory Bowel Disease Products, Services and Solutions

5.5.4 Abbott Laboratories Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)

5.5.5 Abbott Laboratories Recent Developments

5.6 Pluristem Therapeutics

5.6.1 Pluristem Therapeutics Profile

5.6.2 Pluristem Therapeutics Main Business

5.6.3 Pluristem Therapeutics Inflammatory Bowel Disease Products, Services and Solutions

5.6.4 Pluristem Therapeutics Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)

5.6.5 Pluristem Therapeutics Recent Developments

5.7 Pfizer

5.7.1 Pfizer Profile

5.7.2 Pfizer Main Business

5.7.3 Pfizer Inflammatory Bowel Disease Products, Services and Solutions

5.7.4 Pfizer Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)

5.7.5 Pfizer Recent Developments

5.8 AstraZeneca

5.8.1 AstraZeneca Profile

5.8.2 AstraZeneca Main Business

5.8.3 AstraZeneca Inflammatory Bowel Disease Products, Services and Solutions

5.8.4 AstraZeneca Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)

5.8.5 AstraZeneca Recent Developments

5.9 Cephalon

5.9.1 Cephalon Profile

5.9.2 Cephalon Main Business

5.9.3 Cephalon Inflammatory Bowel Disease Products, Services and Solutions

5.9.4 Cephalon Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)

5.9.5 Cephalon Recent Developments

5.10 Amgen

5.10.1 Amgen Profile

5.10.2 Amgen Main Business

5.10.3 Amgen Inflammatory Bowel Disease Products, Services and Solutions

5.10.4 Amgen Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)

5.10.5 Amgen Recent Developments

6 North America

6.1 North America Inflammatory Bowel Disease Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Inflammatory Bowel Disease Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Inflammatory Bowel Disease Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Inflammatory Bowel Disease Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Inflammatory Bowel Disease Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Inflammatory Bowel Disease Market Dynamics

11.1 Inflammatory Bowel Disease Industry Trends

11.2 Inflammatory Bowel Disease Market Drivers

11.3 Inflammatory Bowel Disease Market Challenges

11.4 Inflammatory Bowel Disease Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Bristol Myers Squibb Company

Baxter International

Johnson & Johnson

Sanofi Aventis

Abbott Laboratories

Pluristem Therapeutics

Pfizer Inc

Astrazeneca plc

Cephalon

Amgen Inc

List of Tables

Table 1. Global Market Inflammatory Bowel Disease Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Inflammatory Bowel Disease Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Inflammatory Bowel Disease Market Size Share by Region (2018-2023)

Table 4. Global Inflammatory Bowel Disease Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Inflammatory Bowel Disease Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Inflammatory Bowel Disease Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Inflammatory Bowel Disease Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Inflammatory Bowel Disease Revenue Market Share by Type (2018-2023)

Table 9. Global Inflammatory Bowel Disease Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Inflammatory Bowel Disease Revenue Market Share by Type (2024-2029)

Table 11. North America Inflammatory Bowel Disease Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Inflammatory Bowel Disease Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Inflammatory Bowel Disease Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Inflammatory Bowel Disease Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Inflammatory Bowel Disease Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Inflammatory Bowel Disease Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Inflammatory Bowel Disease Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Inflammatory Bowel Disease Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Inflammatory Bowel Disease Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Inflammatory Bowel Disease Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Inflammatory Bowel Disease Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Inflammatory Bowel Disease Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Inflammatory Bowel Disease Revenue Market Share by Application (2018-2023)

Table 24. Global Inflammatory Bowel Disease Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Inflammatory Bowel Disease Revenue Market Share by Application (2024-2029)

Table 26. North America Inflammatory Bowel Disease Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Inflammatory Bowel Disease Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Inflammatory Bowel Disease Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Inflammatory Bowel Disease Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Inflammatory Bowel Disease Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Inflammatory Bowel Disease Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Inflammatory Bowel Disease Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Inflammatory Bowel Disease Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Inflammatory Bowel Disease Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Inflammatory Bowel Disease Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Inflammatory Bowel Disease Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Inflammatory Bowel Disease Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease as of 2022)

Table 39. Date of Key Players Enter into Inflammatory Bowel Disease Market

Table 40. Global Inflammatory Bowel Disease Key Players Headquarters and Area Served

Table 41. Inflammatory Bowel Disease Product Solution and Service

Table 42. Global Inflammatory Bowel Disease Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Bristol-Myers Squibb Company Basic Information List

Table 45. Bristol-Myers Squibb Company Description and Business Overview

Table 46. Bristol-Myers Squibb Company Inflammatory Bowel Disease Products, Services and Solutions

Table 47. Revenue (US$ Million) in Inflammatory Bowel Disease Business of Bristol-Myers Squibb Company (2018-2023)

Table 48. Bristol-Myers Squibb Company Recent Developments

Table 49. Baxter International Basic Information List

Table 50. Baxter International Description and Business Overview

Table 51. Baxter International Inflammatory Bowel Disease Products, Services and Solutions

Table 52. Revenue (US$ Million) in Inflammatory Bowel Disease Business of Baxter International (2018-2023)

Table 53. Baxter International Recent Developments

Table 54. Johnson & Johnson Basic Information List

Table 55. Johnson & Johnson Description and Business Overview

Table 56. Johnson & Johnson Inflammatory Bowel Disease Products, Services and Solutions

Table 57. Revenue (US$ Million) in Inflammatory Bowel Disease Business of Johnson & Johnson (2018-2023)

Table 58. Johnson & Johnson Recent Developments

Table 59. Sanofi-Aventis Basic Information List

Table 60. Sanofi-Aventis Description and Business Overview

Table 61. Sanofi-Aventis Inflammatory Bowel Disease Products, Services and Solutions

Table 62. Revenue (US$ Million) in Inflammatory Bowel Disease Business of Sanofi-Aventis (2018-2023)

Table 63. Sanofi-Aventis Recent Developments

Table 64. Abbott Laboratories Basic Information List

Table 65. Abbott Laboratories Description and Business Overview

Table 66. Abbott Laboratories Inflammatory Bowel Disease Products, Services and Solutions

Table 67. Revenue (US$ Million) in Inflammatory Bowel Disease Business of Abbott Laboratories (2018-2023)

Table 68. Abbott Laboratories Recent Developments

Table 69. Pluristem Therapeutics Basic Information List

Table 70. Pluristem Therapeutics Description and Business Overview

Table 71. Pluristem Therapeutics Inflammatory Bowel Disease Products, Services and Solutions

Table 72. Revenue (US$ Million) in Inflammatory Bowel Disease Business of Pluristem Therapeutics (2018-2023)

Table 73. Pluristem Therapeutics Recent Developments

Table 74. Pfizer Basic Information List

Table 75. Pfizer Description and Business Overview

Table 76. Pfizer Inflammatory Bowel Disease Products, Services and Solutions

Table 77. Revenue (US$ Million) in Inflammatory Bowel Disease Business of Pfizer (2018-2023)

Table 78. Pfizer Recent Developments

Table 79. AstraZeneca Basic Information List

Table 80. AstraZeneca Description and Business Overview

Table 81. AstraZeneca Inflammatory Bowel Disease Products, Services and Solutions

Table 82. Revenue (US$ Million) in Inflammatory Bowel Disease Business of AstraZeneca (2018-2023)

Table 83. AstraZeneca Recent Developments

Table 84. Cephalon Basic Information List

Table 85. Cephalon Description and Business Overview

Table 86. Cephalon Inflammatory Bowel Disease Products, Services and Solutions

Table 87. Revenue (US$ Million) in Inflammatory Bowel Disease Business of Cephalon (2018-2023)

Table 88. Cephalon Recent Developments

Table 89. Amgen Basic Information List

Table 90. Amgen Description and Business Overview

Table 91. Amgen Inflammatory Bowel Disease Products, Services and Solutions

Table 92. Revenue (US$ Million) in Inflammatory Bowel Disease Business of Amgen (2018-2023)

Table 93. Amgen Recent Developments

Table 94. North America Inflammatory Bowel Disease Market Size by Country (2018-2023) & (US$ Million)

Table 95. North America Inflammatory Bowel Disease Market Size by Country (2024-2029) & (US$ Million)

Table 96. Europe Inflammatory Bowel Disease Market Size by Country (2018-2023) & (US$ Million)

Table 97. Europe Inflammatory Bowel Disease Market Size by Country (2024-2029) & (US$ Million)

Table 98. Asia-Pacific Inflammatory Bowel Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 99. Asia-Pacific Inflammatory Bowel Disease Market Size by Region (2018-2023) & (US$ Million)

Table 100. Asia-Pacific Inflammatory Bowel Disease Market Size by Region (2024-2029) & (US$ Million)

Table 101. Asia-Pacific Inflammatory Bowel Disease Market Share by Region (2018-2023)

Table 102. Asia-Pacific Inflammatory Bowel Disease Market Share by Region (2024-2029)

Table 103. Latin America Inflammatory Bowel Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 104. Latin America Inflammatory Bowel Disease Market Size by Country (2018-2023) & (US$ Million)

Table 105. Latin America Inflammatory Bowel Disease Market Size by Country (2024-2029) & (US$ Million)

Table 106. Middle East & Africa Inflammatory Bowel Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 107. Middle East & Africa Inflammatory Bowel Disease Market Size by Country (2018-2023) & (US$ Million)

Table 108. Middle East & Africa Inflammatory Bowel Disease Market Size by Country (2024-2029) & (US$ Million)

Table 109. Inflammatory Bowel Disease Market Trends

Table 110. Inflammatory Bowel Disease Market Drivers

Table 111. Inflammatory Bowel Disease Market Challenges

Table 112. Inflammatory Bowel Disease Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Inflammatory Bowel Disease Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Inflammatory Bowel Disease Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Inflammatory Bowel Disease Market Share by Regions: 2022 VS 2029

Figure 4. Global Inflammatory Bowel Disease Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Inflammatory Bowel Disease Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Inflammatory Bowel Disease Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Inflammatory Bowel Disease Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Inflammatory Bowel Disease Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Inflammatory Bowel Disease Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Aminosalicylates

Figure 11. Global Aminosalicylates Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Antibiotics

Figure 13. Global Antibiotics Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Product Picture of Corticosteroids

Figure 15. Global Corticosteroids Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 16. Product Picture of Biologic therapies (biological drugs)

Figure 17. Global Biologic therapies (biological drugs) Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 18. Product Picture of Others

Figure 19. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 20. Global Inflammatory Bowel Disease Market Size Share by Type: 2022 & 2029

Figure 21. North America Inflammatory Bowel Disease Revenue Market Share by Type (2018-2029)

Figure 22. Europe Inflammatory Bowel Disease Revenue Market Share by Type (2018-2029)

Figure 23. Asia-Pacific Inflammatory Bowel Disease Revenue Market Share by Type (2018-2029)

Figure 24. Latin America Inflammatory Bowel Disease Revenue Market Share by Type (2018-2029)

Figure 25. Middle East and Africa Inflammatory Bowel Disease Revenue Market Share by Type (2018-2029)

Figure 26. Hospital Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 27. Clinic Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 28. Others Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 29. Global Inflammatory Bowel Disease Market Size Share by Application: 2022 & 2029

Figure 30. North America Inflammatory Bowel Disease Revenue Market Share by Application (2018-2029)

Figure 31. Europe Inflammatory Bowel Disease Revenue Market Share by Application (2018-2029)

Figure 32. Asia-Pacific Inflammatory Bowel Disease Revenue Market Share by Application (2018-2029)

Figure 33. Latin America Inflammatory Bowel Disease Revenue Market Share by Application (2018-2029)

Figure 34. Middle East and Africa Inflammatory Bowel Disease Revenue Market Share by Application (2018-2029)

Figure 35. Inflammatory Bowel Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 36. Global Top 5 and Top 10 Players Inflammatory Bowel Disease Market Share in 2022

Figure 37. North America Inflammatory Bowel Disease Market Share by Country (2018-2029)

Figure 38. U.S. Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 39. Canada Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 40. Germany Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 41. France Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 42. U.K. Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 43. Italy Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 44. Russia Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 45. Nordic Countries Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 46. Asia-Pacific Inflammatory Bowel Disease Market Share by Region (2018-2029)

Figure 47. China Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 48. Japan Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 49. South Korea Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 50. Southeast Asia Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 51. India Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 52. Australia Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 53. Latin America Inflammatory Bowel Disease Market Share by Country (2018-2029)

Figure 54. Mexico Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 55. Brazil Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 56. Middle East & Africa Inflammatory Bowel Disease Market Share by Country (2018-2029)

Figure 57. Turkey Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 58. Saudi Arabia Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 59. UAE Inflammatory Bowel Disease Market Size (2018-2029) & (US$ Million)

Figure 60. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Respiratory Infection Diagnostic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-39D3651

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Internal Neuromodulation Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-24F2529

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Colon Cancer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions